Methods for monitoring oxidative stress, lipid peroxidation and oxidation resistance of lipoproteins
PM Abuja, R Albertini - Clinica chimica acta, 2001 - Elsevier
After a brief discussion of lipid peroxidation mechanism and the action of antioxidants and
their potential to exhibit prooxidant effects, we give an overview on the clinical relevance of …
their potential to exhibit prooxidant effects, we give an overview on the clinical relevance of …
A staging system for renal outcome and early markers of renal response to chemotherapy in AL amyloidosis
…, A Foli, AD Ho, MV Rosin, R Albertini… - Blood, The Journal …, 2014 - ashpublications.org
The kidney is involved in 70% of patients with immunoglobulin light-chain (AL) amyloidosis,
but little is known on progression or reversibility of renal involvement, and criteria for renal …
but little is known on progression or reversibility of renal involvement, and criteria for renal …
Identification of amyloidogenic light chains requires the combination of serum-free light chain assay with immunofixation of serum and urine
…, L Obici, S Casarini, S Donadei, R Albertini… - Clinical …, 2009 - academic.oup.com
Background: The diagnosis of systemic immunoglobulin light-chain (AL) amyloidosis requires
demonstration of amyloid deposits in a tissue biopsy and amyloidogenic monoclonal light …
demonstration of amyloid deposits in a tissue biopsy and amyloidogenic monoclonal light …
The combination of high-sensitivity cardiac troponin T (hs-cTnT) at presentation and changes in N-terminal natriuretic peptide type B (NT-proBNP) after chemotherapy …
In light-chain (AL) amyloidosis, prognosis is dictated by cardiac dysfunction. N-terminal
natriuretic peptide type B (NT-proBNP) and cardiac troponins (cTn) are used to assess the …
natriuretic peptide type B (NT-proBNP) and cardiac troponins (cTn) are used to assess the …
[HTML][HTML] Post-operative benefits of animal-assisted therapy in pediatric surgery: a randomised study
…, S Mencherini, F Papotti, C Klersy, R Albertini… - PloS one, 2015 - journals.plos.org
Background Interest in animal-assisted therapy has been fuelled by studies supporting the
many health benefits. The purpose of this study was to better understand the impact of an …
many health benefits. The purpose of this study was to better understand the impact of an …
[HTML][HTML] Prevalence and pathogenesis of anemia in inflammatory bowel disease. Influence of anti-tumor necrosis factor-α treatment
G Bergamaschi, A Di Sabatino, R Albertini… - …, 2010 - ncbi.nlm.nih.gov
Background Anemia is a common complication of inflammatory bowel disease, but its
epidemiology may be changing due to earlier diagnosis and improved treatments. We investigated …
epidemiology may be changing due to earlier diagnosis and improved treatments. We investigated …
Best use of cardiac biomarkers in patients with AL amyloidosis and renal failure
…, A Foli, P Milani, P Russo, R Albertini… - American journal of …, 2012 - Wiley Online Library
In AL amyloidosis prognosis depends on the severity of heart dysfunction which is best
assessed by natriuretic peptides (BNP and NT‐proBNP). However, their clearance relies on …
assessed by natriuretic peptides (BNP and NT‐proBNP). However, their clearance relies on …
[HTML][HTML] Anemia of chronic disease and defective erythropoietin production in patients with celiac disease
G Bergamaschi, K Markopoulos, R Albertini… - …, 2008 - haematologica.org
Background Anemia due to hematinic deficiencies is common in patients with untreated
celiac disease. Although celiac disease is a chronic condition characterized by an intense …
celiac disease. Although celiac disease is a chronic condition characterized by an intense …
The sensitivity of versican from rabbit lung to gelatinase A (MMP‐2) and B (MMP‐9) and its involvement in the development of hydraulic lung edema
Large chondroitinsulphate‐containing proteoglycan (versican) isolated from rabbit lung was
cleaved by purified gelatinase A (MMP‐2) and gelatinase B (MMP‐9), as well as by crude …
cleaved by purified gelatinase A (MMP‐2) and gelatinase B (MMP‐9), as well as by crude …
[HTML][HTML] Hemoperfusion with CytoSorb as adjuvant therapy in critically ill patients with SARS-CoV2 pneumonia
We report a preliminary experience of adjuvant therapy with Hemoperfusion (HP) in patients
with Severe Acute Respiratory Syndrome-CoronaVirus 2 (SARS-CoV2) pneumonia. …
with Severe Acute Respiratory Syndrome-CoronaVirus 2 (SARS-CoV2) pneumonia. …